PMA supplement
P150017 S013: Cartiva Synthetic Cartilage Implant (Cartiva SCI)
FDA PMA supplement · Normal 180 Day Track No User Fee · Cartiva, Inc.
Key facts
| Original PMA | P150017 |
|---|---|
| Supplement number | S013 |
| Supplement type | Normal 180 Day Track No User Fee |
| Reason for the supplement | Location Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | Cartiva Synthetic Cartilage Implant (Cartiva SCI) |
| Generic name | Prosthesis, metatarsophalangeal joint cartilage replacement implant |
| Applicant | Cartiva, Inc. |
| Product code | PNW |
| Received date | Aug 5, 2019 |
| Decision date | Feb 9, 2020 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: